The dopamine D2 receptor belongs to the family of seven transmembrane
domain G-protein-coupled receptors and is highly expressed in the cent
ral nervous system and the pituitary gland. The binding of dopamine to
the D2 receptor is crucial for the regulation of diverse physiologica
l functions, such as the control of locomotor activity and the synthes
is of peptide hormones. Two alternatively spliced transcripts are gene
rated from the D2 receptor gene and code for the D2L and D2S isoforms,
which are 444 and 415 amino acids in length, respectively. These isof
orms exhibit similar pharmacological characteristics and are expressed
in the same cell types, with a ratio that normally favors expression
of the longer isoform. The D2L isoform differs from D2S by the inserti
on of 29 amino acids in the putative third intracellular loop of the r
eceptor. This loop is involved in the coupling of the receptor to diff
erent G proteins. Experiments have shown that the D2 isoforms have dif
ferent G-protein-coupling affinities, suggesting that these receptors
might serve different functions in vivo. Additionally, this difference
in coupling affinity could be a mechanism to amplify the signal trans
duced by the binding of dopamine to D2 receptors. Important insights i
nto D2 receptor function in vivo have been obtained by knocking out th
e D2 gene in mice. The Parkinsonian-like phenotype of D2-null mice dem
onstrates the importance of the D2 receptor for locomotor function.